1-3 of 3
Ji Lin
Close
Sort by
Journal Articles

Clinical Activity of Abemaciclib (LY2835219), a Cell Cycle Inhibitor Selective for CDK4 and CDK6, in Patients with Relapsed or Refractory Mantle Cell Lymphoma

Franck Morschhauser, MD PhD, Kamal Bouabdallah, MD, Stephan Stilgenbauer, MD, Catherine Thieblemont, MD PhD, Martin Wolf, MD, Sophie de Guibert, MD, Florian Zettl, MD, Marjo Hahka-Kemppinen, MD PhD, David Xiaohui Wang, MD PhD, Patrick Brueck, MD, Charles Caldwell, MD, Richard Beckmann, PhD, Lawrence Gelbert, PhD, Damien Cronier, PhD, Ji Lin, PhD, Lily Li, MD, Edward M. Chan, MD, Michael Pfreundschuh, Martin Wilhem, MD, Georg Hess, MD
Journal: Blood
Blood (2014) 124 (21): 3067.
https://doi.org/10.1182/blood.V124.21.3067.3067
Published: 2014
Journal Articles

AML1/ETO Cooperates with HIF1α to Promote Leukemogenesis through DNMT3a Transactivation

Xiaoning Gao, Fei Yan, PhD, Ji Lin, Li Gao, Xiaolin Lu, Shengcai Wei, Na Shen, Jiuxia Pang, Qiaoyang Ning, Ailing Deng, Yihan Xu, Jinlong Shi, Yonghui Li, Shujun Liu, PhD, Li Yu
Journal: Blood
Blood (2014) 124 (21): 3543.
https://doi.org/10.1182/blood.V124.21.3543.3543
Published: 2014
Journal Articles

High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

Clinical Trials & Observations
George K. K. Lau, Yu-hung Leung, Daniel Y. T. Fong, Wing-yan Au, Yok-lam Kwong, Albert Lie, Ji-lin Hou, Yu-mei Wen, Amin Nanj, Raymond Liang
Journal: Blood
Blood (2002) 99 (7): 2324–2330.
https://doi.org/10.1182/blood.V99.7.2324
Published: 2002